The biomarker enriched proteome of autosomal dominant polycystic kidney disease cyst fluid

Proteomics - Clinical Applications

Volumn 3, Issue 10, 2009, Pages 1247-1250

  Mason, Stephen B ^a   Lai, Xianyin ^a   Bacallao, Robert L ^a   Biazer Yost, Bonnie L ^b   Gattone II, Vincent H ^a   Wang, Kevin C ^a   Witzmann, Frank A ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b INDIANA UNIVERSITY   (United States)

Author keywords

Albuminome; Biomarker; Carrier protein; Complement; MS

Indexed keywords

ALPHA 1 ANTITRYPSIN; ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; ANTITHROMBIN III; APOLIPOPROTEIN A1; BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 12; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C7; COMPLEMENT COMPONENT C8; COMPLEMENT FACTOR D; COMPLEMENT FACTOR H; CYSTATIN C; CYTOCHROME P450 2A6; CYTOKERATIN 1; CYTOKERATIN 2; DUAL SPECIFICITY PHOSPHATASE; FETUIN A; FIBRINOGEN; GELSOLIN; HEMOPEXIN; HIGH MOLECULAR WEIGHT KININOGEN; HISTIDINE; IMMUNOGLOBULIN LIGHT CHAIN; PANCREATIC RIBONUCLEASE; PIGMENT EPITHELIUM DERIVED FACTOR; PLASMA RETINOL BINDING PROTEIN; PROTHROMBIN; SERUM ALBUMIN; VITAMIN D BINDING PROTEIN;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CYST FLUID; DIAGNOSTIC PROCEDURE; DISEASE MARKER; HUMAN; KIDNEY POLYCYSTIC DISEASE; MOLECULAR MECHANICS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING;

EID: 70350760086     PISSN: 18628346     EISSN: None     Source Type: Journal    
DOI: 10.1002/prca.200800163     Document Type: Article

References (9)

1. Torres, V. E., Harris, P. C., Pirson, Y., Autosomal dominant polycystic kidney disease. Lancet 2007, 369, 1287-1301.
2. Lai, X. Y., Bacallao, R. L., Blazer-Yost, B. L., Hong, S. M. et al., Characterization of the renal cyst fluid proteome in autosomal dominant polycystic kidney disease (ADPKD) patients. Proteomics Clin. Appl. 2008, 2, 1140-1152.
3. Zhou, M., Lucas, D. A., Chan, K. C., Issaq, H. J. et al., An investigation into the human serum "interactome". Electrophoresis 2004, 25, 1289-1298.
4. Gundry, R. L., Fu, Q., Jelinek, C. A., Eyk, J. E. V., Cotter, R. J., Investigation of an albumin-enriched fraction of human serum and its albuminome. Proteomics Clin. Appl. 2007, 1, 73-88.
5. Colantonio, D. A., Dunkinson, C., Bovenkamp, D. E., Van Eyk, J. E., Effective removal of albumin from serum. Proteomics 2005, 5, 3831-3835.
6. Allen, E., Piontek, K. B., Garrett-Mayer, E., Garcia-Gonzalez, M. et al., Loss of polycystin-1 or polycystin-2 results in dysregulated apolipoprotein expression in murine tissues via alterations in nuclear hormone receptors. Hum. Mol. Genet. 2006, 15, 11-21.
7. Mrug, M., Zhou, J., Woo, Y., Cui, X. et al., Overexpression of innate immune response genes in a model of recessive polycystic kidney disease. Kidney Int. 2008, 73, 63-76.
8. Weinstein, T., Hwang, D., Lev-Ran, A., Ori, Y. et al., Excretion of epidermal growth factor in human adult polycystic kidney disease. Isr. J. Med. Sci. 1997, 33, 641-642.
9. Lev-Ran, A., Hwang, D. L., Ahmad, B., Bixby, H., Immunoreactive epidermal growth factor in serum, plasma, platelets, and urine in patients on chronic dialysis. Nephron 1991, 57, 164-166.